IL6 and type 2 diabetes mellitus: Proinflammatory cytokines (particularly interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α)) are chronically increased in diabetic patients and contribute to T2DM development, progression, and complications [3].